DEXRAZOXANE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dexrazoxane, and when can generic versions of Dexrazoxane launch?
Dexrazoxane is a drug marketed by Eugia Pharma, Gland, Hikma, and MSN. and is included in four NDAs.
The generic ingredient in DEXRAZOXANE is dexrazoxane hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dexrazoxane hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dexrazoxane
A generic version of DEXRAZOXANE was approved as dexrazoxane hydrochloride by HIKMA on September 28th, 2004.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DEXRAZOXANE?
- What are the global sales for DEXRAZOXANE?
- What is Average Wholesale Price for DEXRAZOXANE?
Summary for DEXRAZOXANE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Drug Prices: | Drug price information for DEXRAZOXANE |
| DailyMed Link: | DEXRAZOXANE at DailyMed |
US Patents and Regulatory Information for DEXRAZOXANE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | DEXRAZOXANE HYDROCHLORIDE | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 200752-001 | Oct 19, 2011 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Msn | DEXRAZOXANE HYDROCHLORIDE | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 216748-001 | Mar 26, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Gland | DEXRAZOXANE HYDROCHLORIDE | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 207321-001 | Nov 28, 2016 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
